Aortech International PLC
20 January 2006
For immediate release 20 January 2006
AorTech International plc
('AorTech' or 'the Company')
Re: Share Price Movement
The Directors of AorTech note the recent movement in the share price of the
Company and know of no reason for today's increase. AorTech confirms that its
strategy to develop commercial products from its Elast-Eon biomaterial is
progressing in line with the expectations of the management.
In December 2005 the Company reported its Interim Results, in which it gave a
full update to the progress of its research and technical discussions with
potential customers. Further updates will be released as soon as is appropriate.
For further information please contact:
AorTech International plc
Frank Maguire, Chief Executive 00 1 801 201 4336
Buchanan Communications 020 7466 5000
Ben Willey, Rebecca Skye Dietrich
Visit AorTech's website at: www.aortech.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.